Oncology Institute, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -14.32M-10.93M0.15M-83.07M-64.66M
Depreciation and Depletion 0.69M0.83M1.53M2.86M3.19M
Share-based Compensation 0.15M24.54M27.68M17.81M11.15M
Deferred Taxes -1.34M-1.24M-0.26M-0.08M
Gains from Investment Securities 0.21M-24.89M-59.22M-0.80M-0.62M
Asset Writedowns and Impairment 7.50M-0.42M0.48M2.02M
Cash from Operations 0.51M-32.68M-61.76M-36.31M-26.54M
Depreciation, Depletion & Amortization
Amortization of Goodwill 9.94M16.87M
Amortizatization of Intangibles 1.02M2.63M0.50M
Amortization of Deferred Charges 0.06M0.05M2.44M6.21M6.30M
Depreciation & Amortization (CF) 3.18M3.34M4.41M5.87M6.29M
Change in Working Capital
Change in Receivables 6.76M2.19M20.29M4.56M5.97M
Change in Inventory 0.47M1.84M1.73M4.38M-3.64M
Change in Account Payables 3.76M2.92M-6.19M5.06M9.21M
Change in Accured Expenses 5.21M-3.08M2.35M3.36M9.47M
Change in Taxes 0.66M-1.01M0.12M-0.26M
Other Working Capital Changes 1.39M9.09M-4.28M-5.32M-2.83M
Investing Activities
Capital Expenditures 1.19M2.85M5.53M4.57M3.79M
Change in Intangibles 0.20M
Acquisitions 0.15M9.11M8.58M4.46M
Change in Acquisitions & Divestments 81.26M50.00M
Cash from Investing Activities -8.84M-12.15M-131.61M62.64M46.21M
Financing Activities
Other financing activities 0.34M3.66M
Cash from Financing Activities 11.89M154.01M92.21M-6.85M-3.49M
Additional items
Change in Cash 3.55M109.18M-101.16M19.48M16.18M
Beginning Cash Balance 2.45M6.00M115.17M14.01M33.49M
Free Cash Flow -0.69M-35.53M-67.28M-40.88M-30.33M
Net Cash Flow 3.55M109.18M-101.16M19.48M16.18M